Shows / Vital Health Podcast
Vital Health Podcast
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and…
Episodes
Vital Health PodcastThe IRA Promised Lower Drug Prices. Why Did It Cut Follow-On Cancer Research?
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Harry Bowen, Economics Research Partner at Vital Transformation, about their…
Vital Health PodcastEric Lindquist: Why Did Pfizer License a Promising Cancer Drug to Celcuity?
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Eric Lindquist, biotech entrepreneur and former Chief Business and Commercial…
Vital Health PodcastVT Discusses MFN and Price Controls
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Harry Bowen, Economic Research Partner at Vital Transformation, about…
Vital Health PodcastMichael Penn: What The IRA Means For Oncology Innovation
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Michael Penn, US Head of Reimbursement and Public Policy at Sanofi, to discuss…
Vital Health PodcastMSD Early Bird Podcast: Changing Demographics and the Case for Renewed Investment in Health
Across Europe and around the world, demographic change is reshaping our societies. Longer life expectancy, aging populations, and evolving workforce dynamics…
Vital Health PodcastBill Smith: How 340B Became A Hospital Profit Center
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Bill Smith (Senior Fellow and Director, Life Sciences Initiative at The Pioneer…
Vital Health PodcastSteve Potts: Policy Headwinds Are Reshaping Biotech Financing
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Steve Potts, CEO of Breakthru Medicine, to discuss how biotech financing, drug…
Vital Health PodcastPatrick Kelly & John Murphy: Generic Shortages and Supply Chain Risk
In this best-of edition of the Vital Health Podcast, we revisit two conversations Duane Schulthess has with experts on the future of generic medicines, drug…
Vital Health PodcastChristopher Locher: Why Vaccine Innovation Matters More Than Ever
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Christopher Locher, Chief Executive Officer at Versatope Therapeutics, about the…
Vital Health PodcastMelanie Whittington: Why Are Drugs So Expensive?
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Melanie Whittington, Managing Director and Head of the Leerink Center for…
Vital Health PodcastVT's Grumpies and Lady Discuss the U.S. Biotech Policy Landscape
Read our MFN preprint: https://vitaltransformation.com/2026/02/preprint-new-research-the-impact-of-mfn-on-oncology-and-hematology-treatments/ In this episode…
Vital Health PodcastTim Scott: MFN Pricing, Venture Risk, and the Future of California Biotech
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Tim Scott, President & CEO of Biocom California, a biopharma executive with more…
Vital Health PodcastMark Rohrbaugh & Gwen O’Loughlin: Drug Patents, March-In Rights, and NIH Technology Transfer
In this episode of the Vital Health Podcast, host Duane Schulthess examines how NIH-funded research fits into the U.S. innovation and IP ecosystem, and why…
Vital Health PodcastOriana Ciani & Denis Lacombe: Overall Survival and Surrogate Endpoints in Early Oncology Approvals
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two experts on evidence standards for early oncology access at ISPOR Europe 2025…
Vital Health PodcastAnja Schiel & Nicholas Hedberg: Accelerated Approvals, Evidence Gaps, and Reimbursement Risk
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two experts on reimbursement-facing evidence questions for accelerated oncology…
Vital Health PodcastKathleen Grieve, Martina Garau, & Bettina Ryll: Accelerating Patient Access To Cancer Medicines In Europe
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with three experts on accelerated patient access to cancer medicines at ISPOR Europe…
Vital Health Podcast2025 US Policy Highlights - Inflation Reduction Act (IRA) Part 2
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on the Inflation Reduction Act…
Vital Health Podcast2025 US Policy Highlights - Most Favored Nation (MFN)
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on Most Favored Nation (MFN)…
Vital Health Podcast2025 U.S. Policy Highlights - Inflation Reduction Act (IRA) Part 1
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on the Inflation Reduction Act…
Vital Health PodcastSteffen Thirstrup & Richard Bergstrom: Evidence, Access, and Competitiveness in Europe
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two experts in European regulation and evidence of new medicines: Steffen…
Vital Health PodcastMalina Müller: Rethinking Accelerated Approvals in Europe
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Dr. Malina Müller, Head of Health Economics at WifOR Institute, to explore…
Vital Health PodcastVT's Grumpies Talk MFN
In this episode of the Vital Health Podcast, host Duane Schulthess sits down with two Vital Transformation colleagues to explore key trends in drug pricing and…
Vital Health PodcastBettina Ryll, Kjetil Taskén & Anni Lepland: PRIME-ROSE & EU Joint Action
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with three leaders advancing precision cancer medicine implementation in Europe…
Vital Health PodcastJohn Murphy: Generics, Biosimilars, and U.S. Policy
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with John Murphy, President and CEO of the Association for Accessible Medicines…
Vital Health PodcastPatrick Kelly: Inside the Generic Supply Chain Squeeze
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Patrick Kelly, Chief Advocacy Officer at the Healthcare Distribution Alliance…
Vital Health PodcastLieven Annemans & Andreas Charalambous: Moving the Needle in EU Cancer Care
In this Vital Health Podcast, host Duane Schulthess speaks with two leading European voices on oncology and health economics: Andreas Charalambous: Chair of…
Vital Health PodcastKirsten Axelsen: Part D Shift, IRA Penalties, and Access Risks
Kirsten Axelsen is an economist specializing in Medicare reimbursement, payer negotiations, and innovative reimbursement contracts. She’s a fellow of the…
Vital Health PodcastBest-of Edition: Pernille Weiss & Niklas Blomberg on EU Pharma Policy
In this "Best-of" edition of the Vital Health Podcast, Duane Schulthess revisits two listener favorites on the future of medicines in Europe. First, former MEP…
Vital Health PodcastHenry Skinner: Fixing the Antibiotics Market & Confronting AMR
In this Vital Health Podcast, host Duane Schulthess - joined by Joe Hammang, Vital Transformation's US Business Director - speaks with Henry Skinner (CEO, AMR…
Vital Health PodcastBest-of Edition: Peter Kolchinsky & John LaMattina on the IRA
In this “Best of” edition, host Duane Schulthess revisits two landmark conversations on the long-term impact of the Inflation Reduction Act (IRA)…
Vital Health PodcastBarbara McAneny, Rafael Fonseca, and Steve Potts: Protecting Patients Amid the IRA
In this episode of the Vital Health Podcast, host Duane Schulthess convenes three leading voices from the 2025 BIO International Convention - prominent…
Vital Health PodcastSam Rasty, Steve Potts, and Joe Hammang: Policies, Patients, and the Biotech Narrative
In this episode, Duane Schulthess is joined by Sam Rasty, Chief Business Officer at Sensorium Therapeutics, Steve Potts, Chair of the Drug Development Council…
Vital Health PodcastIpsita Smolinski: Drug Pricing, R&D, & Global Policy
In this episode, host Duane Schulthess sits down with Ipsita Smolinski, Founder and Managing Director of Capitol Street and faculty at Georgetown University…
Vital Health PodcastStrengthening Biotech Ecosystems: Steve Potts & Robert Coughlin
In this Vital Health Podcast episode, host Duane Schulthess sits down with Steve Potts, biopharma entrepreneur and chair of the Drug Development Council…
Vital Health PodcastJocelyn Ulrich: PBMs, Policy Risk, and Biopharma’s Future
In this Vital Health Podcast, host Duane Schulthess speaks with Jocelyn Ulrich, Vice President of Policy and Research at PhRMA, to discuss the far-reaching…
Vital Health PodcastJenni Nordborg: Life Sciences Governance & EU Regulatory Alignment
In this episode of the Vital Health Podcast, host Duane Schulthess sits down with Jenni Nordborg, Director of International Affairs at The Swedish Association…
Vital Health PodcastDonna Cryer: Advocacy, Drug Incentives & Research Crisis
In this episode of the Vital Health Podcast, host Duane Schulthess sits down with patient advocate and Global Liver Institute founder Donna Cryer. They trace…
Vital Health PodcastVT’s Grumpies Talk IRA with Virginia Acha
In this special Grumpies episode, host Duane Schulthess, CEO of Vital Transformation, is joined by neuroscientist and US Business Director Joe Hammang…
Vital Health PodcastSteve Usdin: Tariffs, Price Controls, & Inflation Reduction Act (IRA)
In this episode, host Duane Schulthess sits down with Steve Usdin, Senior Washington Editor at BioCentury Publications since 1993 and one of the most cited…
Vital Health PodcastExpanding Oncology Treatments: PRIME-ROSE and the Future of Drug Repurposing
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two key voices driving the PRIME-ROSE initiative: Gro Live Fagereng, Project…
Vital Health PodcastBreaking Barriers: The Prime Rose Project and Off-Label Drug Innovations
Join host Duane Schulthess on the Vital Health Podcast as he explores the groundbreaking Prime Rose Project, an initiative redefining the use of off-label…
Vital Health PodcastImpact of the Inflation Reduction Act on Venture Capital in Life Sciences
In this Vital Health Podcast, John Stanford, Executive Director of Incubate, discusses the impact of the Inflation Reduction Act (IRA) on venture capital…
Vital Health PodcastInvesting in Health: Pathways to a Well-being Economy and Smarter Healthcare Budgets
In this insightful episode of the Vital Health Podcast, we dive deep into the economic and societal benefits of investing in healthcare. Our esteemed guests…
Vital Health PodcastAddressing Europe's Health Challenges: Innovation, Prevention, and Policy
Join us at the Gastein Health Conference for an insightful conversation on Europe's healthcare challenges and innovations! Host Duane Schulthess sits down with…
Vital Health PodcastThe Future of Biotech: Steve Potts on Innovation, Policy, and the Impact of the IRA
In this episode of the Vital Health podcast, host Duane Schulthess sits down with Steve Potts, a seasoned entrepreneur and CEO of SLAM BioTherapeutics. They…
Vital Health PodcastRevolutionizing Healthcare with Real-World Data
In the latest episode of the Vital Health podcast, we delve into the future of healthcare with Blythe Adamson from Flatiron Health. Learn how Flatiron is at…
Vital Health PodcastExploring the Intersection of Intellectual Property and Biotech Innovation
In the latest episode of the Vital Health podcast, we engage in a thought-provoking discussion with Hans Sauer, Deputy General Counsel for Intellectual…
Vital Health PodcastUnlocking the Power of Genomic Data: NashBIO's Role in Healthcare Innovation
In this episode of the Vital Health podcast, we dive deep into the world of genomic data and its transformative impact on healthcare. Join host Duane…
Vital Health PodcastMEP Pernille Weiss – Rapporteur of the EU GPL
In this Vital Health Podcast, Duane Schulthess speaks to Pernille Weiss, a former Member of the European Parliament and the Rapporteur of the European…
Vital Health PodcastTransforming Health Communications: Insights from Virginia Amann
Join us at the International 2024 BIO conference as host Duane Schulthess sits down with Virginia Amann, CEO of the Entente Network. Discover how Virginia has…
Vital Health PodcastJoe Panetta – Policy Impacts on California Biopharma
With the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for…
Vital Health PodcastNiklas Blomberg, Executive Director, EU Innovative Health Initiative
In this Vital Health Podcast, recorded live at the 2024 Bio International Conference, host Duane Schulthess sits down with Niklas Blomberg, the Executive…
Vital Health PodcastCongressman Michael Burgess – IRA and March-in Rights
Congressman Michael Burgess is the Chair of the House Rules Committee and one of only 20 M.D.s currently serving in Congress. Before his election to the House…
Vital Health PodcastKim Hawkins - Project Co-Lead of IMI’s Trials@Home
Trials@Home is a €39 million, pan-European public private partnership of the EU’s Innovative Medicines Initiative, focused on defining the best practices to…
Vital Health PodcastDouglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA”
Douglas Holtz-Eakin was formerly a professor of economics at Syracuse University and served as the director of the Congressional Budget Office from 2003 –…
Vital Health PodcastJohn LaMattina – Drug Price Controls and IP Attacks Get Real
John LaMattina was President of Pfizer Global Research and Development and ran an international team of over 13,000 scientists and professionals. He has…
Vital Health PodcastKate Hudson & Joseph P. Allen – The Fact Free Attacks on IP
This podcast features Kate Hudson, the Associate Vice President and Counsel for Policy at the Association of American Universities, and Joseph P. Allen, the…
Vital Health PodcastVT’s Grumpy Old Men – The Administration’s Threats to use March-In Rights
On December 8, 2023, The Biden Administration under the National Institute of Standards and Technology (“NIST”) released a Draft Interagency Guidance Framework…
Vital Health PodcastPRIME-ROSE: The EU’s DRUP Trial Champion
With a six million EUR funding grant from the European Commission, the PRIME-ROSE project will implement, across Europe, a series of prospective…
Vital Health PodcastPeter Kolchinsky - "IRA's 9 Years Is Too Short"
In this Vital Health Podcast, Duane Schulthess speaks with Peter Kolchinsky, Managing Partner at RA Capital Management. Peter has authored several critically…